This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Scheven, M. Articles by Schwegler, F. Search for Related Content PubMed PubMed Citation Articles by Scheven, M. Articles by Schwegler, F.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, 08 1995, 1779-1783, Vol 39, No. 8
Copyright © 1995 by the American Society for Microbiology. All rights reserved.

Antagonistic interactions between azoles and amphotericin B with yeasts depend on azole lipophilia for special test conditions in vitro

M Scheven and F Schwegler
Laborpraxis Dr. Reinhofer, Greiz, Germany.

The interactions of the azole antifungal agents fluconazole, itraconazole, ketoconazole, or miconazole with amphotericin B (AmB) in their effect on Candida albicans were investigated. These four azoles antagonized the fungistatic activity of AmB at sub-MICs if both substances acted simultaneously. This coincubation test was primarily developed to observe the azole-mediated demethylase inhibition quantitatively by bioassay. Interestingly, the occurrence of azole-AmB antagonism depended on azole lipophilia if specially selected test conditions were applied. By a consecutive incubation regimen, preincubation at high azole concentrations (1 to 50 micrograms/ml) and then subsequent incubation with AmB (1 microgram/ml), only preincubation with the three lipophilic azoles decreased the fungicidal activity of AmB but not that of FCZ. It was shown that yeasts absorb only lipophilic azoles to a remarkable extent. This fact might be responsible for the absence of antagonism of FCZ to AmB when yeasts were incubated consecutively. It can be concluded with caution that consecutive treatment of candidiasis with FCZ and AmB does not necessarily result in a clinically relevant antagonism.

This article has been cited by other articles:

• Bhattacharya, A., Mishra, L. C., Bhasin, V. K. (2008). In Vitro Activity of Artemisinin in Combination with Clotrimazole or Heat-treated Amphotericin B against Plasmodium falciparum. Am J Trop Med Hyg 78: 721-728 [Abstract] [Full Text]  
• Meletiadis, J., Stergiopoulou, T., O'Shaughnessy, E. M., Peter, J., Walsh, T. J. (2007). Concentration-Dependent Synergy and Antagonism within a Triple Antifungal Drug Combination against Aspergillus Species: Analysis by a New Response Surface Model. Antimicrob. Agents Chemother. 51: 2053-2064 [Abstract] [Full Text]  
• Antachopoulos, C., Meletiadis, J., Sein, T., Roilides, E., Walsh, T. J. (2007). Use of high inoculum for early metabolic signalling and rapid susceptibility testing of Aspergillus species. J Antimicrob Chemother 59: 230-237 [Abstract] [Full Text]  
• O'Shaughnessy, E. M., Meletiadis, J., Stergiopoulou, T., P. Demchok, J., Walsh, T. J. (2006). Antifungal interactions within the triple combination of amphotericin B, caspofungin and voriconazole against Aspergillus species. J Antimicrob Chemother 58: 1168-1176 [Abstract] [Full Text]  
• Cuenca-Estrella, M. (2004). Combinations of antifungal agents in therapy-what value are they?. J Antimicrob Chemother 54: 854-869 [Abstract] [Full Text]  
• Johnson, M. D., MacDougall, C., Ostrosky-Zeichner, L., Perfect, J. R., Rex, J. H. (2004). Combination Antifungal Therapy. Antimicrob. Agents Chemother. 48: 693-715 [Full Text]  
• Yoon, S. A., Vazquez, J. A., Steffan, P. E., Sobel, J. D., Akins, R. A. (1999). High-Frequency, In Vitro Reversible Switching of Candida lusitaniae Clinical Isolates from Amphotericin B Susceptibility to Resistance. Antimicrob. Agents Chemother. 43: 836-845 [Abstract] [Full Text]  
• Vazquez, J. A., Arganoza, M. T., Boikov, D., Yoon, S., Sobel, J. D., Akins, R. A. (1998). Stable Phenotypic Resistance of Candida Species to Amphotericin B Conferred by Preexposure to Subinhibitory Levels of Azoles. J. Clin. Microbiol. 36: 2690-2695 [Abstract] [Full Text]